Clinical Trial Update: Single-Arm Exploratory Study of PD-L1 Antibody Plus Neoadjuvant Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2, single-arm exploratory study evaluating a PD-L1–targeting antibody plus neoadjuvant chemotherapy for locally advanced head and neck squamous cell car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• PD-L1 antibody

Snippet

Sponsor: Xiuping Ding | Conditions: Squamous Cell Carcinoma of Head and Neck | Phase 2 | Status: RECRUITING